Enanta Pharmaceuticals | ENTA - Rentabilidad Por Dividendo

Precio De Mercado
12.69
Cambio Diario
0.18 1.44%
Mensual
-13.97%
Anual
104.68%
Q1 Expectativa
12.13




Dy Cambio Fecha
AbbVie 2.91 0.58 2025-12
Amgen 2.95 0.38 2025-12
Anika Therapeutics 0 0 2025-03
AstraZeneca USD 1.74 0.4 2025-12
BioCryst Pharmaceuticals 0 0 2025-03
Bristol-Myers Squibb 0.22 0.04 2025-12
Enanta Pharmaceuticals 0 0 2025-03
Gilead Sciences 2.58 0.25 2025-12
GlaxoSmithKline 4.57 1.52 2025-12
Heron Therapeutics 0 0 2025-03
J&J 2.5 0.32 2025-12
Karyopharm Therapeutics 0 0 2025-03
Merck 3.12 0.74 2025-12
Novartis USD 3.05 0.26 2025-12
Pfizer 6.91 0.33 2025-12
Roche Holding 2.96 0.8 2025-12